8.23 USD
↘ 0.81 (8.96%)AT CLOSE (11:59 AM EDT)
SELLAS Life Sciences Group, Inc. Common Stock
SLSNASDAQ • USD
8.29
↗ 0.06 (0.68%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
8.29
↗ 0.06 (0.68%)
Market: CLOSED
Open?$8.85
High?$9.03
Low?$8.13
Prev. Close?$9.04
Volume?6.7M
Avg. Volume?9.3M
VWAP?$8.49
Rel. Volume?0.72x
Bid / Ask
Bid?$8.25 × 2.9K
Ask?$8.31 × 400
Spread?$0.06
Midpoint?$8.28
Valuation & Ratios
Market Cap?1.6B
Shares Out?196.6M
Float?147.9M
Float %?98.7%
P/E Ratio?N/A
P/B Ratio?15.07
EPS?-$0.15
Dividend?0.00%
Ex-Dividend?N/A
SELLAS Life Sciences Group, Inc. Common Stock (SLS) trades at $8.23 per share. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, SLS is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
Themes
Employees
13
Market Cap
1.6B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2008-03-12
Address
7 TIMES SQUARE
NEW YORK, NY 10036
Phone: (646) 200-5278
NEW YORK, NY 10036
Phone: (646) 200-5278
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?65
Short Sent.?36
Piotroski F-Score?0/9Weak
Altman Z-Score?140.24Safe
Confidence?45%Low
Short InterestSqueeze Risk
Short % of Float?38.59%Squeeze Risk
Short Interest?57.1M
Days to Cover?7.1
Free Float147.9M
Avg Daily Volume8.0M
Settlement Date2026-05-15
Financial Health
Current Ratio?17.20Strong
Quick Ratio?17.20Strong
Cash Ratio?16.59Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?15.07HIGH▾
Peers100
S&P12
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-48.0CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-27.4%WEAK▾
S&P6
ROA?-25.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$1.5B
Fundamentals ratios updated end of day